Tomorrow's Session: Patient Advocacy Beyond the Walk
|
Hi! As a reminder, our next Patient Advocacy & Engagement Roundtable event is tomorrow, October 29th. On the surface, patient advocacy can be associated with awareness campaigns, fundraising walks, and patient storytelling. But of course, the function extends well beyond those activities, influencing everything from research and clinical development to organizational strategy and decision-making. Tomorrow, our PA&E Roundtable members will challenge common assumptions about the function and explore what communicators should understand -- and embrace -- about the work. Patient Advocacy Beyond the Walkπ Tomorrow, Thursday, October 29th @ 12-1 p.m. ET / 9-10 a.m. PT / 4-5 p.m. GMT βRegister hereβ Free and exclusive to T2B Pro and Student members. Our speakersTomorrow's session features T2B PA&E Roundtable members: π¬ Susan Brisendine, Founder and Principal, Conduit Health Collective π¬ Erin Murphy, Global Strategy & Partnerships and Communications, Alagille Syndrome Alliance π¬ Jonathan Naylor, Associate Director, Patient Advocacy, DISC Medicine π¬ Lauren Walrath, Head of US Communications and Media, Organon π¬ Michele Lentz, Founder/CEO, Stand up for Patients (Moderator) Whether you're directly responsible for patient advocacy or encounter it through corporate communications, disease education, clinical milestones, or patient storytelling, this is a chance to develop a different perspective about the function and the role we can play in supporting meaningful patient engagement. Hope to see you tomorrow! Lynnea |
T2B Monthly
Hi! We're headed back to London next month for the Jefferies Healthcare Conference and London Life Sciences Week! With an increasingly international audience gathering for the conference, we're looking forward to bringing together more of our global T2B community through two events focused on giving back and connecting with fellow biopharma communicators. Even if you're not making the trip, we'd love your help spreading the word! Please share these invitations with UK-based colleagues,...
Hi! Many of the decisions weβre asked to make have no clear or obvious correct answer. Taking a public position on an issue may reassure employees, but create political or commercial exposure. Staying silent may protect the company legally but undermine trust with patients or other stakeholders. And sometimes, the pressure to respond quickly doesn't leave much room to think through the longer-term implications. At this Friday's Comm Convo, we'll explore how communicators can help leadership...
Hi! China's role in global biopharma has changed dramatically over the past few years, evolving from a lower-cost manufacturing and research hub into a major source of innovation, drug development, and licensing activity. At the same time, geopolitical tensions and shifting U.S. policies have raised questions about cross-border partnerships, investment, intellectual property, and supply chains. At our upcoming Media Minds Roundtable press panel, we'll hear from Drew Armstrong (Endpoints) and...